1,752
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Immune checkpoint inhibitors of the PD-1/PD-L1-axis in non-small cell lung cancer: promise, controversies and ambiguities in the novel treatment paradigm

, , &
Pages 360-369 | Received 06 Dec 2019, Accepted 10 Mar 2020, Published online: 02 Apr 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.